Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET.

Abstract

These findings indicate that regional metabolic covariance patterns are robust imaging markers of disease severity. FDG-PET may be useful clinically in assessing parkinsonian disability and disease progression.